{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:28:44Z","timestamp":1784042924918,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773163"],"award-info":[{"award-number":["81773163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.breast.2020.07.009","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T12:37:00Z","timestamp":1596631020000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-4760","authenticated-orcid":false,"given":"Jinfei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Eric","family":"Pazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-3867","authenticated-orcid":false,"given":"Zihao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-5362","authenticated-orcid":false,"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2020.07.009_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2020.07.009_bib2","first-page":"22","article-title":"Current cancer situation in China: good or bad news from the 2018 global cancer statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Canc Commun"},{"key":"10.1016\/j.breast.2020.07.009_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-016-3947-0","article-title":"Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence","volume":"159","author":"Li","year":"2016","journal-title":"Breast Canc Res Treat"},{"issue":"69","key":"10.1016\/j.breast.2020.07.009_bib4","first-page":"438","article-title":"Breast cancer statistics","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2020.07.009_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JOP.2015.008953","article-title":"Curing metastatic breast cancer","volume":"12","author":"Sledge","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.breast.2020.07.009_bib6","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.2967\/jnumed.115.157834","article-title":"Clinical diagnosis and management of breast cancer","volume":"57","author":"McDonald","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.breast.2020.07.009_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","article-title":"Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer","volume":"21","author":"Henderson","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.07.009_bib8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(16)32616-2","article-title":"11 years\u2019 follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial","volume":"389","author":"Cameron","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2020.07.009_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1703643","article-title":"Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer","volume":"377","author":"Von Minckwitz","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2020.07.009_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2020.07.009_bib11","author":"National Comprehensive Cancer Network","year":"2020","journal-title":"National comprehensive cancer network guidelines for breast cancer"},{"key":"10.1016\/j.breast.2020.07.009_bib12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00417-019-04337-8","article-title":"Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics","volume":"257","author":"Kunkler","year":"2019","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejca.2013.10.016","article-title":"Ocular adverse events of molecularly targeted agents approved in solid tumours: a systematic review","volume":"50","author":"Huillard","year":"2014","journal-title":"Eur J Canc"},{"key":"10.1016\/j.breast.2020.07.009_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and humanistic burden of dry eye disease in europe, north America, and asia: a systematic literature review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.breast.2020.07.009_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.breast.2020.07.009_bib16","article-title":"Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis","volume":"8","author":"Song","year":"2018","journal-title":"J\u00a0Glob Health"},{"key":"10.1016\/j.breast.2020.07.009_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.breast.2020.07.009_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.breast.2020.07.009_bib19","doi-asserted-by":"crossref","DOI":"10.1089\/photob.2019.4788","article-title":"Subjective quality of vision in evaporative dry eye patients after intense pulsed light","author":"Fan","year":"2020","journal-title":"Photobiomodulation, Photomedicine, Laser Surg"},{"key":"10.1016\/j.breast.2020.07.009_bib20","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0039-6257(00)00200-9","article-title":"The pathology of dry eye","volume":"45","author":"Baudouin","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib21","first-page":"23","article-title":"Principles of oncologic pharmacotherapy","author":"Takimoto","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2020.07.009_bib22","series-title":"Eye symptoms and toxicities of systemic chemotherapy. MASCC textb. Cancer support. Care surviv","first-page":"563","author":"Prensky","year":"2018"},{"key":"10.1016\/j.breast.2020.07.009_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/02713683.2011.594202","article-title":"Breast cancer medications and vision: effects of treatments for early-stage disease","volume":"36","author":"Eisner","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.breast.2020.07.009_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.12968\/bjcn.2008.13.10.31184","article-title":"Dry eye syndrome (DES) and watering eyes","volume":"13","author":"Redmond","year":"2008","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.breast.2020.07.009_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICU.0b013e32832c9007","article-title":"Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients","volume":"20","author":"Hazin","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/OPTH.S228070","article-title":"A\u00a0review of topical cyclosporine a formulations\u2014 a disease-modifying agent for keratoconjunctivitis Sicca","volume":"14","author":"Jerkins","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.breast.2020.07.009_bib28","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1167\/iovs.11-8027","article-title":"Rasch analysis of the ocular surface disease index (OSDI)","volume":"52","author":"Dougherty","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.breast.2020.07.009_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jval.2011.08.1739","article-title":"Priority symptoms in advanced breast cancer: development and initial validation of the national comprehensive cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)","volume":"15","author":"Garcia","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.breast.2020.07.009_bib30","author":"Krohe"},{"key":"10.1016\/j.breast.2020.07.009_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.eye.6701314","article-title":"Detection of Oestrogen receptors (ER) \u03b1 and \u03b2 in conjunctiva, lacrimal gland, and tarsal plates","volume":"18","author":"Spelsberg","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.breast.2020.07.009_bib32","first-page":"1906","article-title":"Estrogen receptor in the human eye: influence of gender and age on gene expression","volume":"40","author":"Ogueta","year":"1999","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.breast.2020.07.009_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0002-9394(99)80190-1","article-title":"Long-term tamoxifen citrate use and potential ocular toxicity","volume":"125","author":"Gorin","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-006-9486-3","article-title":"Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors","volume":"106","author":"Eisner","year":"2007","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.07.009_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.breast.2015.08.008","article-title":"Dry eyes and AIs: if you don\u2019t ask you won\u2019t find out","volume":"24","author":"Inglis","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.breast.2020.07.009_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1574886312666170919175614","article-title":"Cyclophosphamide and\/or anthracyclines induced epiphora in breast cancer patients: a rare side-effect","volume":"13","author":"Kalra","year":"2018","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.breast.2020.07.009_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","article-title":"The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents","volume":"48","author":"Rowinsky","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.breast.2020.07.009_bib38","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1200\/JCO.2005.04.4453","article-title":"Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel","volume":"24","author":"Esmaeli","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2020.07.009_bib39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archopht.120.9.1180","article-title":"Docetaxel secretion in tears: association with lacrimal drainage obstruction","volume":"120","author":"Esmaeli","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib40","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6605268","article-title":"Chemotherapy for early-stage breast cancer: a brief history","volume":"101","author":"Verrill","year":"2009","journal-title":"Br J Canc"},{"key":"10.1016\/j.breast.2020.07.009_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.IOP.0000066648.33513.3D","article-title":"Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-Fluorouracil","volume":"19","author":"Eiseman","year":"2003","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.breast.2020.07.009_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.survophthal.2005.11.001","article-title":"Update on ocular complications of systemic cancer chemotherapy","volume":"51","author":"Schmid","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.breast.2020.07.009_bib43","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2012.45.6574","article-title":"Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy","volume":"31","author":"Chan","year":"2013","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2020.07.009_bib44","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1200\/JCO.2009.23.8451","article-title":"Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study","volume":"28","author":"Untch","year":"2010","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2020.07.009_bib45","first-page":"51","article-title":"Dry eye syndrome in menopause and perimenopausal age group","volume":"8","author":"Peck","year":"2017","journal-title":"J\u00a0Midlife Health"},{"key":"10.1016\/j.breast.2020.07.009_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-009-0478-y","article-title":"Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva","volume":"120","author":"Bouchardy","year":"2010","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2020.07.009_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/GME.0000000000000530","article-title":"Dry eye in postmenopausal women","volume":"23","author":"Sriprasert","year":"2016","journal-title":"Menopause"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762030151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762030151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:44Z","timestamp":1778570564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762030151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":47,"alternative-id":["S096097762030151X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2020.07.009","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2020.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}